The PAH Risk Score Calculator App

Easily calculate PAH risk scores on your phone or tablet

The pulmonary arterial hypertension (PAH) risk calculators from the PAH Initiative can help you quickly calculate your patients risk score on your phone or tablet with point-and-click ease.

The PAH Risk Score Calculators app include 5 calculators to choose from depending on which risk assessment methodology works best for your practice —REVEAL 2.0, REVEAL Lite 2, 2022 ESC/ERS 3-strata baseline calculator, 4-strata COMPERA 2.0 for follow-up risk assessment, and French noninvasive criteria.

Treatment guidelines recommend using an objective, multiparameter risk assessment at diagnosis and follow-up as you aim for low-risk status and help improve your patients chance of survival.^1-4

This app is intended for US healthcare providers treating patients with pulmonary arterial hypertension (PAH), to assist in the calculation of risk scores according to the 2022 ESC/ERS PH Guidelines, COMPERA 2.0 4-Risk Strata, French Noninvasive Criteria, REVEAL 2.0, and REVEAL Lite 2 methods These calculators do not provide a specific preventative, diagnostic, or treatment course or replace a clinician's independent judgment when using these tools.

United Therapeutics and the PAH Initiative
As a public benefit corporation, United Therapeutics is committed to improving the lives of PAH patients. With support from United Therapeutics, the PAH Initiative provides non-branded, disease education and resources for the PAH community.

Various calculators on the PAH Risk Score Calculator app

What to expect with the PAH Risk Score Calculators

Calculate a risk score in less than 30 seconds using an intuitive touch interface

5 available risk assessment methodologies for baseline or follow-up scoring

Knowing your patient's risk status let you use your clinical judgment to help them get to low risk

Print or email results to yourself or staff for patient records

No risk calculation or user data are stored or transmitted

Favorite your preferred calculators for future use

About the PAH Initiative

As a public benefit corporation, United Therapeutics is committed to improving the lives of patients and supporting those who care for them. Founded by parents of a daughter with PAH, we understand what it’s like to be in an exam room when a patient is told that they have PAH, and we know the challenges of living with this disease. That’s why UT sponsors the PAH Initiative. The PAH Initiative seeks to further our commitment by educating, enabling and inspiring the PAH community to advance PAH patient care.

Whether you occasionally see patients with PAH, or you are a dedicated PAH specialist, the PAH Initiative provides clinically useful information and practical tools to help you improve the lives of your patients with PAH.

The PAH Initiative provides:

Information on the diagnosis and treatment of PAH
In-depth discussion on the pathophysiology of PAH
Data showing the importance of risk assessment in determining prognosis
Risk calculators to assess the risk score of patients
Information on treatment approaches
Resources including podcasts by experts in PAH, recent publications about PAH
Educational resources for your patients

Visit PAHInitiative.com/hcp to learn more

Side by side view of various calculators on the PAH Risk Score Calculator app

References: 1. Boucly A, et al. Eur Respir J. 2017;50(2):1700889. 2. Hoeper MM, et al. Eur Respir J. 2017;50(2):1700740. 3. Kylhammar D, et al. Eur Heart J. 2018;39(47):4175-4181. 4. Benza RL, et al. Chest. 2019;156(2):323-337.